Singapore, as the premier biomedical sciences hub of Asia, is at the forefront of adopting Multiplex Diagnostic Systems. With the Ministry of Health's focus on "Healthier SG" and the Research, Innovation and Enterprise (RIE) 2025 plan, the demand for sophisticated molecular testing has surged. Unlike traditional single-target PCR, multiplexing allows for the simultaneous detection of multiple pathogens from a single clinical specimen, which is critical for Singapore’s efficient healthcare management.
In high-density urban environments like Singapore, rapid turnaround times for infectious disease screening—ranging from respiratory panels to tropical diseases like Dengue and Zika—are vital. Hospitals in the SingHealth and National University Health System (NUHS) networks increasingly rely on these systems to reduce patient wait times and optimize isolation protocols in wards. Our supply chain bridge from Shenzhen to Singapore ensures that the latest fluorescence-based detection technologies are readily available for both human clinical and veterinary applications.
Analytical Accuracy
Optical Channels
Rapid Test Cycles
Global Certification
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
By leveraging the "Silicon Valley of Hardware" in Shenzhen, we provide Singaporean exporters and medical distributors with a unique combination of high-speed R&D and cost-effective production. Our proximity to the world's most robust electronics supply chain allows us to integrate 18.5'' RGB Lvds Interface LCDs and high-precision PMT Smart Inspection Modules into our systems at a fraction of the cost of Western competitors, without compromising on quality.
The global molecular diagnostic market is moving toward "Syndromic Testing"—a method where a single test covers a broad spectrum of pathogens that cause similar symptoms. Our systems are designed to support this trend, featuring up to 6 channels for complex multiplexing. In the Singapore context, this is particularly relevant for the National Centre for Infectious Diseases (NCID), where rapid differentiation between viral and bacterial infections can save lives.
AI Integration: Modern diagnostics are no longer just about detection; they are about data. Our latest Real-Time Fluorescence PCR Analyzers feature cloud-connectivity and AI-assisted interpretation of amplification curves. This reduces the risk of human error in clinical settings and allows for real-time epidemiological tracking—a key pillar of Singapore's digital health transformation.
Veterinary Excellence: Singapore’s rising pet ownership and the presence of world-class zoological institutions like Mandai Wildlife Reserve have created a niche demand for high-end veterinary diagnostics. Our Sy-W007-1 series provides rapid 4-channel imaging specifically optimized for zoonotic diseases, ensuring animal health is monitored with the same rigor as human health.
Singapore serves as a vital gateway for medical devices entering the Southeast Asian (ASEAN) market. Many Singapore-based exporters procure our Multiplex Diagnostic Systems for redistribution to Malaysia, Indonesia, and Vietnam. Our team provides comprehensive support for this "Hub-and-Spoke" distribution model, including:
Our systems are manufactured under ISO 13485 standards and carry CE marking. We provide all necessary technical documentation (Product Summary, STED) to help Singapore importers complete their Class B or C medical device registration with the Health Sciences Authority.
Our PCR-Chip Hybridization technology, such as the Gastrointestinal Pathogens Kit, can detect over 20 different pathogens in a single run, providing a comprehensive syndromic profile for clinical laboratories.
We work with several local distributors in the Biopolis and Tuas areas who provide on-site installation, calibration, and training. For complex integration, our Shenzhen-based engineering team offers 24/7 remote technical support.
Yes, our fully automatic PCR analyzers are equipped with standard LIS/HIS connectivity interfaces (HL7 protocol compatible), allowing seamless data transfer from the lab to the patient record.
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine. Whether you are a private clinic in Orchard Road, a research lab in Biopolis, or a veterinary hospital in Jurong, our multiplex solutions are engineered to exceed your expectations.
BioX Medical
